BioProcess International European Summit

CPhI Worldwide

BioProcess International European Summit gives you access to innovative science and technology across the entire bioprocessing spectrum. Accelerate your biologics, mAbs, vaccines and novel products towards commercial success.

Increase specific Influenza production with recombinant human insulin

The vaccine industry is challenged to produce large quantities of vaccines in a rapid and cost-effective way. Major changes to current bioprocesses are both difficult and very
expensive to implement. It has been demonstrated using HEK293 cells that addition of animal origin free human insulin to commercially available off-the-shelf chemically defined
media, can be used as a supplement to increase VCD, productivity and specific viral yield.

Read the full study

Read more about our Insulin Human AF or contact us.

 

Contact

Vanessa León

International Marketing Manager

Email

Direct phone: +45 4042 6284